Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis.

PubWeight™: 5.15‹?› | Rank: Top 1%

🔗 View Article (PMC 268925)

Published in J Clin Microbiol on September 01, 1986

Authors

W Langenberg, E A Rauws, A Widjojokusumo, G N Tytgat, H C Zanen

Articles citing this

Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75

The genus Campylobacter: a decade of progress. Clin Microbiol Rev (1988) 5.49

Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun (1989) 3.81

Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates. J Clin Microbiol (1992) 3.56

Construction of a Helicobacter pylori genome map and demonstration of diversity at the genome level. J Bacteriol (1992) 3.16

Detection of Helicobacter pylori by using the polymerase chain reaction. J Clin Microbiol (1991) 2.84

Molecular cloning and expression of Campylobacter pylori species-specific antigens in Escherichia coli K-12. Infect Immun (1989) 2.81

Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol (1990) 2.55

Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol (1990) 2.53

Ribotyping of Helicobacter pylori from clinical specimens. J Clin Microbiol (1992) 2.35

Use of plasmid profiles in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance. Clin Microbiol Rev (1988) 2.35

Restriction endonuclease analysis of Staphylococcus epidermidis DNA may be a useful epidemiological marker. J Clin Microbiol (1988) 2.27

Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol (1997) 2.18

PCR-based restriction fragment length polymorphism typing of Helicobacter pylori. J Clin Microbiol (1994) 1.96

Evaluation of 13C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non-ulcer dyspepsia. Gut (1990) 1.92

Rapid identification of Campylobacter pylori (C. pyloridis) by preformed enzymes. J Clin Microbiol (1987) 1.79

Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide. J Clin Microbiol (1996) 1.78

Restriction fragment length polymorphisms in the ribosomal genes for species identification and subtyping of aerotolerant Campylobacter species. J Clin Microbiol (1991) 1.77

Evidence for the occurrence of the same strain of Campylobacter pylori in the stomach and dental plaque. J Clin Microbiol (1989) 1.71

Comparison of methods for discrimination between strains of Listeria monocytogenes from epidemiological surveys. Appl Environ Microbiol (1991) 1.69

Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC. J Clin Microbiol (1995) 1.67

Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter. J Bacteriol (1995) 1.61

Evaluation of restriction endonuclease fingerprinting of chromosomal DNA and plasmid profile analysis for characterization of multiresistant coagulase-negative staphylococci in bacteremic neonates. J Clin Microbiol (1990) 1.60

Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints. Infect Immun (1989) 1.57

Detection of Campylobacter pylori in stomach tissue by DNA in situ hybridisation. J Clin Pathol (1989) 1.53

Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: a potential model for gastritis in man. Gut (1988) 1.52

Signature patterns of DNA restriction fragments of Helicobacter pylori before and after treatment. J Clin Pathol (1990) 1.44

Gastric colonization by Campylobacter pylori subsp. mustelae in ferrets. Infect Immun (1988) 1.35

Detection of genomic heterogeneity in Streptococcus suis isolates by DNA restriction fragment length polymorphisms of rRNA genes (ribotyping). J Clin Microbiol (1995) 1.35

High prevalence of Helicobacter pylori infection in cohabiting children. Epidemiology of a cluster, with special emphasis on molecular typing. Gut (1994) 1.33

Western immunoblotting with five Treponema pallidum recombinant antigens for serologic diagnosis of syphilis. Clin Diagn Lab Immunol (2001) 1.30

Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease. J Clin Microbiol (1996) 1.29

Evaluation of two monkey species (Macaca mulatta and Macaca fascicularis) as possible models for human Helicobacter pylori disease. J Clin Microbiol (1990) 1.27

Rapid fingerprinting of Helicobacter pylori by polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1993) 1.26

Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother (1993) 1.25

Similar DNA restriction endonuclease profiles in strains of Legionella pneumophila from different serogroups. J Clin Microbiol (1988) 1.23

The fimbria gene cluster of nonencapsulated Haemophilus influenzae. Infect Immun (1998) 1.23

Comparison of PCR-based restriction length polymorphism analysis of urease genes with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy. J Clin Microbiol (1994) 1.22

Allelic variation in the Helicobacter pylori flagellin genes flaA and flaB: its consequences for strain typing schemes and population structure. Epidemiol Infect (1995) 1.21

Application of different chromosomal DNA restriction digest fingerprints to specific and subspecific identification of Campylobacter isolates. J Clin Microbiol (1989) 1.20

Antigenicity of Helicobacter pylori lipopolysaccharides. J Clin Microbiol (1992) 1.19

A comparison of DNA and immunoblot fingerprinting of the SII biotype of coagulase negative staphylococci. Epidemiol Infect (1988) 1.19

Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy. Antimicrob Agents Chemother (1990) 1.19

Typing of Aeromonas strains by DNA restriction endonuclease analysis and polyacrylamide gel electrophoresis of cell envelopes. J Clin Microbiol (1989) 1.17

Characterization of adherence of nontypeable Haemophilus influenzae to human epithelial cells. Infect Immun (2000) 1.12

Differentiation of Helicobacter pylori strains directly from gastric biopsy specimens by PCR-based restriction fragment length polymorphism analysis without culture. J Clin Microbiol (1997) 1.10

A highly specific and sensitive DNA probe derived from chromosomal DNA of Helicobacter pylori is useful for typing H. pylori isolates. J Clin Microbiol (1993) 1.06

Transmission of Helicobacter pylori infection. Gut (1995) 1.03

Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci (1997) 1.02

Phosphoinositide3-kinase regulates actin polymerization during delayed phagocytosis of Helicobacter pylori. J Leukoc Biol (2005) 1.01

Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol (1994) 0.99

Helicobacter pylori infection in India from a western perspective. Indian J Med Res (2012) 0.97

Helicobacter pylori: bridging the credibility gap. Gut (1990) 0.97

Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrob Agents Chemother (1995) 0.95

Selected cryopreservatives for long term storage of Helicobacter pylori at low temperatures. J Clin Pathol (1992) 0.92

Secretion of intravenously administered antibiotics in gastric juice: implications for management of Helicobacter pylori. J Clin Pathol (1992) 0.91

Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. Gut (1995) 0.90

Genetic variability and molecular typing of Shigella sonnei strains isolated in Canada. J Clin Microbiol (1994) 0.88

DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole. J Clin Pathol (1992) 0.87

Analysis of southern Ontario Actinobacillus (Haemophilus) pleuropneumoniae isolates by restriction endonuclease fingerprinting. Can J Vet Res (1990) 0.86

Differentiation of Achromobacter-like strains from human blood by DNA restriction endonuclease digest and ribosomal RNA gene probe patterns. Epidemiol Infect (1990) 0.86

The nucleotide excision repair (NER) system of Helicobacter pylori: role in mutation prevention and chromosomal import patterns after natural transformation. BMC Microbiol (2012) 0.83

13C-urea breath test for Helicobacter pylori infection. Gut (1991) 0.81

Analysis of a single Helicobacter pylori strain over a 10-year period in a primate model. Int J Med Microbiol (2015) 0.80

Cloning of genes of nontypeable Haemophilus influenzae involved in penetration between human lung epithelial cells. Infect Immun (2000) 0.78

Direct evidence by DNA fingerprinting that endoscopic cross-infection of Helicobacter pylori is a cause of postendoscopic acute gastritis. J Clin Microbiol (2000) 0.77

Pathophysiology and clinical relevance of Helicobacter pylori. Yale J Biol Med (1994) 0.76

Helicobacter pylori reinfection. Gut (1996) 0.75

Systemic chemotherapy for Helicobacter pylori eradication? Gut (1990) 0.75

Articles by these authors

Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet (1990) 9.49

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73

Meningitis caused by Streptococcus suis in humans. Rev Infect Dis (1988) 5.84

Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27

The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69

Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39

Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology (1989) 4.23

Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis (1993) 3.92

Functional gastroduodenal disorders. Gut (1999) 3.74

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22

Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet (1997) 3.12

Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications. Endoscopy (1996) 3.12

Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol (1983) 2.96

Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology (2001) 2.85

Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet (1986) 2.76

Recurrent massive haematemesis from Dieulafoy vascular malformations--a review of 101 cases. Gut (1986) 2.74

Regular review: treatment of Helicobacter pylori infection. BMJ (2000) 2.73

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis (1996) 2.66

Characteristics of major outer membrane proteins of Haemophilus influenzae. J Bacteriol (1983) 2.66

Molecular epidemiology of Legionella pneumophila serogroup 1. J Clin Microbiol (1984) 2.60

Clostridial toxin in faeces of healthy infants. Lancet (1978) 2.58

Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol (1990) 2.55

Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54

Homogeneity of cell envelope protein subtypes, lipopolysaccharide serotypes, and biotypes among Haemophilus influenzae type b from patients with meningitis in The Netherlands. J Infect Dis (1983) 2.51

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38

The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology (1999) 2.37

Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea. J Clin Microbiol (1987) 2.34

Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers. J Gen Microbiol (1980) 2.32

Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter (1996) 2.26

Collagenous sprue--an unrecognized type of malabsorption. N Engl J Med (1970) 2.21

Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol (1997) 2.18

Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology (1996) 2.17

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther (1999) 2.14

Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12

Phenotypic characterization and DNA relatedness in human fecal isolates of Aeromonas spp. J Clin Microbiol (1989) 2.09

Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis (1998) 2.09

Self-expanding metal stents in benign biliary strictures due to chronic pancreatitis. Endoscopy (2004) 2.08

Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology (1978) 2.07

[Obstructive jaundice after surgery of the biliary tract, a benign stricture or not?]. Ned Tijdschr Geneeskd (2004) 2.05

[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04

Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96

Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J Infect Dis (1990) 1.96

HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut (1999) 1.94

Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology (1984) 1.89

14C-urea breath test in C pylori gastritis. Gut (1989) 1.89

Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc (1997) 1.88

Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol (1992) 1.88

Variability of low-molecular-weight, heat-modifiable outer membrane proteins of Neisseria meningitidis. Infect Immun (1980) 1.85

cagA-positive Helicobacter pylori populations in China and The Netherlands are distinct. Infect Immun (1998) 1.84

Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol (1996) 1.84

Endoscopic palliative treatment in pancreatic cancer. Gastrointest Endosc (1986) 1.84

Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg (1997) 1.84

Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations. Gut (1976) 1.83

Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients. Gastrointest Endosc (1995) 1.82

Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol (1996) 1.80

A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology (1997) 1.79

A study of 280 cases of neonatal meningitis in The Netherlands. J Infect (1984) 1.79

Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76

Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology (1988) 1.75

Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology (1999) 1.74

Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol (1995) 1.74

Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect Immun (1989) 1.74

Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy: a prospective analysis. Ann Surg (2001) 1.71

Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology (1989) 1.70

Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension. Eur J Gastroenterol Hepatol (1996) 1.70

Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol (1997) 1.69

Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis (1990) 1.69

Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology (1990) 1.67

Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67

Impaired anamnestic cellular immune response in patients with Crohn's disease. Gut (1975) 1.65

A patient with osteomalacia as single presenting symptom of gluten-sensitive enteropathy. J Intern Med (1992) 1.64

Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg (2001) 1.62

Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology (1995) 1.61

What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree. Endoscopy (2011) 1.61

Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J Infect Dis (1988) 1.59

Benign biliary strictures. Surgery or endoscopy? Ann Surg (1993) 1.59

Intestinal endotoxemia. Clinical significance. Gastroenterology (1988) 1.59

Loss of E-cadherin expression in early gastric cancer. Histopathology (1999) 1.59

Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg (1990) 1.58

Immunogenicity of meningococcal antigens as detected in patient sera. Infect Immun (1983) 1.58

Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.57